879127-07-8

879127-07-8 structure

Name: EGFR-IN-12
Chemical Name: N-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide
CAS Number: 879127-07-8
Molecular Formula: C₂₁H₁₈F₃N₅O
Molecular Weight: 413.396
Catalog: Signaling Pathways Apoptosis Apoptosis
Create Date: 2016-09-14 06:44:03
Modify Date: 2024-01-18 16:17:53
EGFR-IN-12 is a 4,6-disubstituted pyrimidine and is a potent, ATP-competitive, irreversible and highly selective EGFR inhibitor with an IC50of 21 nM. EGFR-IN-12 also inhibits mutant EGFRL858R and EGFRL861Q with IC50s of 63 nM and 4 nM, respectively. EGFR-IN-12 displays strong selectivity for EGFR over HER4 (IC50 = 7640 nM) and a panel of 55 other kinases. EGFR-IN-12 induces cells apoptosis and has antitumor activity[1][2].

Name	N-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide
Synonyms	N-(3-((6-((3-(Trifluoromethyl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)cyclopropanecarboxamide N-{3-[(6-{[3-(Trifluoromethyl)phenyl]amino}-4-pyrimidinyl)amino]phenyl}cyclopropanecarboxamide N-{3-[(6-{[3-(trifluoromethyl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}cyclopropanecarboxamide Cyclopropanecarboxylic acid-(3-(6-(3-trifluoromethyl-phenylamino)-pyrimidin-4-ylamino)-phenyl)-amide EGFR Inhibitor HMS3229E03 Cyclopropanecarboxamide, N-[3-[[6-[[3-(trifluoromethyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-

Description	EGFR-IN-12 is a 4,6-disubstituted pyrimidine and is a potent, ATP-competitive, irreversible and highly selective EGFR inhibitor with an IC50of 21 nM. EGFR-IN-12 also inhibits mutant EGFRL858R and EGFRL861Q with IC50s of 63 nM and 4 nM, respectively. EGFR-IN-12 displays strong selectivity for EGFR over HER4 (IC50 = 7640 nM) and a panel of 55 other kinases. EGFR-IN-12 induces cells apoptosis and has antitumor activity[1][2].
Related Catalog	Signaling Pathways >> Apoptosis >> Apoptosis Research Areas >> Cancer Signaling Pathways >> JAK/STAT Signaling >> EGFR Signaling Pathways >> Protein Tyrosine Kinase/RTK >> EGFR
Target	EGFR (WT):21 nM (IC50) EGFRL858R:63 nM (IC50) EGFRL861Q:4 nM (IC50) HER4:7640 nM (IC50)
In Vitro	EGFR-IN-12 (EGFR inhibitor 324674; 0-2 µM; 48 hours; HT29 and SW480 cells) treatment efficiently induces apoptosis at lower concentrations[2]. EGFR-IN-12 (EGFR inhibitor 324674; 0-3 µM; 3 hours; HT29 and SW480 cells) treatment inhibits EGFR activation and the downstream AKT signaling pathway in a dose-dependent manner[2]. EGFR-IN-12 (EGFR inhibitor 324674) inhibits HT29 and SW480 cell proliferation with with IC50s of 1.96 µM and 1.04 µM, respectively[2]. Pretreatment of cells with EGFR-IN-12 (compound 1; 10 µM) results in complete inhibition of wild-type receptor autophosphorylation in U-2OS cells. And the T766M mutant receptor is completely resistant to inhibition by EGFR-IN-12[1]. Apoptosis Analysis[1] Cell Line: HT29 and SW480 cells Concentration: 0 µM, 1 µM, 2 µM Incubation Time: 48 hours Result: Induced apoptosis in HT29 cells and SW480 cells. Western Blot Analysis[1] Cell Line: HT29 and SW480 cells Concentration: 0 µM, 0.1 µM, 0.3 µM, 1 µM, 3 µM Incubation Time: 3 hours Result: Inhibited EGFR activation and the downstream AKT signaling pathway in a dose-dependent manner.
References	[1]. Qiong Zhang, et al. Discovery of EGFR Selective 4,6-disubstituted Pyrimidines From a Combinatorial Kinase-Directed Heterocycle Library. J Am Chem Soc. 2006 Feb 22;128(7):2182-3. [2]. Zhiwei Yu, et al. Novel Irreversible EGFR Tyrosine Kinase Inhibitor 324674 Sensitizes Human Colon Carcinoma HT29 and SW480 Cells to Apoptosis by Blocking the EGFR Pathway. Biochem Biophys Res Commun. 2011 Aug 12;411(4):751-6.

Density	1.5±0.1 g/cm3
Boiling Point	605.9±55.0 °C at 760 mmHg
Molecular Formula	C₂₁H₁₈F₃N₅O
Molecular Weight	413.396
Flash Point	320.2±31.5 °C
Exact Mass	413.146332
PSA	82.43000
LogP	5.71
Vapour Pressure	0.0±1.7 mmHg at 25°C
Index of Refraction	1.682

879127-07-8	2407957-87-1
1660963-42-7	2754392-31-7
2375470-64-5	2752328-62-2
2747133-37-3	2749562-63-6
2648206-31-7	2634646-14-1